A leading rheumatologist is calling for answers after a hydroxychloroquine shortage prevents his patients from accessing treatment.

Quebec-based company donates one million doses of anti-malaria drug hydroxychloroquine in the fight against COVID-19, despite it not being approved for that purpose by Health Canada.